The classic function for thioredoxin is to act as a hydrogen donor for the enzyme ribonucleotide reductase, which is essential for DNA synthesis. In addition, thioredoxin participates in the regulation of different metabolic processes via thiol redox control. These kind of processes involve changes in the activity of different enzymes, receptors or transcription factors via dithiol/disulphide interchange reactions. Thioredoxin is present in the human decidua and trophoblasts. This study was performed to investigate whether thioredoxin mRNA is present in the human cervix, and differently expressed during pregnancy as compared with the nonpregnant state. Cervical biopsies and serum samples were obtained from 28 late pregnant, 41 post-partum and 15 non-pregnant menstruating women. The tissues were analysed for thioredoxin mRNA content using a solution hybridization technique. The thioredoxin mRNA level increased 3-fold at late pregnancy in comparison with the non-pregnant state. No further increase was seen immediately after parturition, either after spontaneous delivery or after pharmacological induction. There was a positive correlation between the cervical thioredoxin mRNA level and the serum oestradiol concentration in the non-pregnant group. We suggest that thioredoxin mRNA in the human cervix is regulated, at least partly, by oestradiol.
Introduction
Thioredoxin is a protein disulphide reductase, which plays a key role in many redox reactions, such as the synthesis of deoxyribonucleic acids (DNA) by ribonucleotide reductase, the regulation of transcription factors or in antioxidative defence (Holmgren, 1985; Holmgren and Björnstedt, 1995) . Thioredoxin, which is usually located in the cytosol, is secreted by human activated lymphocytes and liver cells (Rubartelli et al., 1992; Rosén et al., 1995) . It operates in synergy with cytokines to stimulate cell growth and can activate protein kinase C (Biguet et al., 1994) . The thioredoxin system has also been shown to be involved in the cleavage of S-nitrosoglutathione, which results in liberation of nitric oxide (NO) and glutathione (Nikitovic and Holmgren, 1996) .
During pregnancy the human cervix experiences a structural remodelling of the connective tissue, clinically recognized as softening and dilatation . Just before the onset of labour a final, rapid cervical softening occurs, corresponding to a degradation of primarily the extracellular matrix (Osmers et al., 1992) . Increased values of collagenase and leukocyte elastase have been found during the process of final ripening Osmers et al., 1992) . Neutrophils, eosinophils and fibroblasts are known to secrete collagenase (Osmers et al., 1992; Jeziorska et al., 1996) . The final ripening of the human cervix has been compared to an inflammatory reaction (Liggins, 1981) , and in accordance with this an infiltration of cervical tissue with inflammatory cells has been shown (Junqueira et al., 1980) . At term, neutrophils and macrophages have been shown to be present in the human cervix in significantly higher numbers than during the first trimester, indicating a role for these cells during cervical ripening (Bokström et al., 1997) . NO synthesis and nitrite production has been shown to be increased in the rat cervical tissue during term labour compared with the non-pregnant and late pregnant state (Buhimschi et al., 1996) . An antiprogestin (onapristone) increased the cervical production of NO while continuous treatment with progesterone in late pregnancy had the opposite effect (Buhimschi et al., 1996) .
Thioredoxin has been demonstrated in human decidua and trophoblasts, where it was suggested to protect the fertilized egg and placental trophoblasts from the cytotoxic effects of oxygen radicals (Kabayashi et al., 1995; Perkins et al., 1995) . Otherwise nothing is known about the expression of thioredoxin in the human uterus during late pregnancy and parturition. In a study on ovariectomized rats we found that oestradiol treatment increases the level of thioredoxin mRNA in the uterus (Sahlin et al., 1997) .
In this study we investigated whether thioredoxin mRNA is present in the human cervical tissue, and whether the level is different in pregnant and non-pregnant women, in order to gain further information about the mechanisms behind the remodelling of the cervix.
Materials and methods

Patients
The non-pregnant group consisted of 15 regularly menstruating women with a mean age of 46 years (range 38-51), and a mean parity of 1.6 (range 0-4). All were hysterectomized due to benign disorders not involving the cervix.
The late pregnant group consisted of 28 healthy pregnant women with a mean age of 33 years (range 23-41), a mean gestational age of 38 weeks (range 37-40) and a mean parity of 1.6 (range 0-3). All women had unripe cervices with a Bishop score Ͻ5 points and none of them was in labour. Elective Caesarean sections on medical indications were carried out in all women. Biopsies were obtained during operation.
The post-partum group consisted of 26 women from which biopsies were taken within 15 min after spontaneous vaginal delivery. They had a mean age of 29 years (range 25-35), a mean gestational age of 40 weeks (range 38-42) and a mean parity of 1.2 (range 1-2).
The prostaglandin (PG)-treated group consisted of 10 women with unripe cervices (Bishop score Ͻ5 points) who were treated with 0.5 mg PGE 2 in a viscous gel (dinoproston, Cerviprost ® , Organon International, Oss, The Netherlands) intracervically to induce cervical ripening and initiation of labour, due to medical reasons including oligohydramniosis, post-maturity and accelerated fetal growth. The biopsies were taken within 15 min after vaginal delivery. These women had a mean age of 31 years (range 21-37), a mean gestational age of 41 weeks (range 40-42) and a mean parity of 1.3 (range 1-2). Four women needed addition of 0.5 mg PGE 2 intracervically or 2 mg PGE 2 -gel vaginally (dinoproston, Minprostin ® , Upjohn) due to insufficient ripening at examination after 24 h.
The RU486 group consisted of five women treated with 400 mg antiprogestin (Mifepristone ® , Roussel-Aclaf, France) orally to induce cervical ripening and induction of labour, due to post-maturity. The biopsies were taken within 15 min after vaginal delivery. They had a mean age of 27 years (range 21-36), a mean gestational age of 42 weeks (range 42-42) and a mean parity of 1.0 (range 1-1).
All women gave their informed consent and the study was approved by the local Ethics Committee of the Karolinska hospital.
Sampling procedure
The biopsies were taken transvaginally from the anterior cervical lip at the 12 o'clock position, from 10-20 mm depth. The mucosa was carefully removed and the biopsies were placed on dry ice and stored at -70°C until analysed. Serum samples were obtained simultaneously, centrifuged within 30 min at 3000 g for 10 min and stored at -20°C. The serum concentrations of oestradiol and progesterone were quantified by radioimmunoassay (Sufi et al., 1995) .
Preparation of total nucleic acids
Total nucleic acids (TNA) were prepared by digestion of homogenized tissue with proteinase K in a sodium dodecyl sulphate (SDS)-containing buffer, followed by subsequent extraction with phenolchloroform as described before (Stjernholm et al., 1996) . The concentration of DNA in the samples was measured fluorometrically at the wavelength 458 nm with Hoechst Dye 33258.
Hybridization probes
The probe used for the thioredoxin mRNA determinations was derived from a genomic clone of human thioredoxin complementary DNA as described previously by Lippoldt et al. (1995) . A fragment of 315 bp representing the 105 amino acids in the open-reading frame of the human thioredoxin gene was subcloned into a pGEM 3Z 1114 vector. Two subclones with opposite orientations were selected and digested with SmaI. Sense and anti-sense RNA were obtained using T7 RNA polymerase. RNA probes were synthesized by in-vitro transcription using the T7 RNA polymerase promoter. For solution hybridization the probe was labelled with 35 S and for Northern blots with 32 P.
Hybridization analysis of mRNA A solution hybridization assay of specific mRNA was used and performed as described previously (Stjernholm et al., 1996) . The method was modified to allow quantitative measurement of mRNA, as follows: the radioactivity of the sample was compared with a standard curve of known amounts of mRNA synthesized in vitro and complementary to the probe used. Results were expressed as amol (10 -18 )/µg DNA in the TNA samples.
Northern blot analysis of thioredoxin mRNA A multiple tissue Northern blot containing poly(A)ϩRNA prepared from specific tissues (MTN; Clontech, Palo Alto, CA, USA) was prehybridized at 55°C in a solution containing 50% formamide, 5 mM sodium phosphate (pH 6.5), 5ϫ SSC (1ϫ SSC ϭ 0.15 M NaCl/0.015 M sodium citrate), 0.1% SDS, 1 mM EDTA, 0.05% Ficoll, 0.05% polyvinylpyrrolidone, 0.05% bovine serum albumin and 200 µg/ml denatured salmon sperm DNA. After 4 h a 32 P-labelled thioredoxin probe (1ϫ10 6 c.p.m./ml prehybridization solution) was added and hybridization was performed at 60°C for 40 h. Thereafter the filter was washed in 0.1% SDS, 0.1ϫ SSC for 20 min at room temperature and 3ϫ20 min at 65°C. The X-ray film (Amershamhyperfilm MP) was exposed for 20 h at -70°C using intensifying screens.
Statistical analysis
Values are given as median and range. Statistical calculations were performed with the Kruskal-Wallis test, significance was evaluated with Dunn's test and P Ͻ 0.05 was considered to be significant. Correlation was determined by Spearman's rank correlation test.
Results
The human thioredoxin cRNA probe hybridized to a multiple tissue Northern blot of human mRNA exhibiting a single band in all tissues on the blot. Skeletal muscle, uterus (no endometrium), colon (no mucosa), small intestine, bladder, heart, stomach and prostate all showed a single band at 0.6 kb (Figure 1) . The thioredoxin mRNA level increased 3-fold in the late pregnant group (median 4.71; range 1.72-13.2 amol/µg DNA) compared with the non-pregnant (1.49; 0.85-2.77) P Ͻ 0.05 (Figure 2) . The post-partum groups also had increased levels of thioredoxin mRNA. The spontaneous delivered women had a cervical level 4-fold (5.90; 1.59-12.1) that of the nonpregnant group P Ͻ 0.05 (Figure 2 ). The PGE 2 treated women had 3.5-fold (5.23; 2.45-8.53) the thioredoxin mRNA level of the non-pregnant P Ͻ 0.05 (Figure 2) . The women where delivery was induced by RU 486 had a 4.5-fold higher thioredoxin mRNA level (7.15; 2.95-11.2) than the nonpregnant group P Ͻ 0.05 (Figure 2 ). There was no significant difference between the late pregnant and post-partum groups.
The serum concentrations of oestradiol and progesterone are shown in Table I . The values of both hormones were A box and whisker plot representing the median mRNA levels of thioredoxin in cervical samples from non-pregnant (NP), late pregnant (LP) and post partal women (of whom 26 had spontaneous vaginal deliveries (PP), 10 were treated with prostaglandin-E2 (PG) and 5 were treated with an antiprogestin (RU). 50% of all data fall within the box, and 25% each above and below. The 'whiskers' extend to the 5th and 95th percentiles. *P Ͻ 0.05 compared with the non-pregnant group. increased in pregnant and post-partum women compared with the non-pregnant, P Ͻ 0.05.
There was a positive correlation between the thioredoxin mRNA level and the serum oestradiol concentration in the non-pregnant women (P ϭ 0.00266) (Figure 3 ). In contrast, no correlation was found with the serum progesterone concentration (data not shown).
When the effect of age on thioredoxin mRNA was examined, all groups of patients except the late pregnant group (P ϭ 0.81) showed a decrease with age (non-pregnant, P ϭ 0.002; post-partum group, P ϭ 0.0005).
Discussion
In this study we have shown that thioredoxin mRNA is present in the human cervix. In the non-pregnant women the thioredoxin mRNA was correlated with the serum oestradiol concentration. This was not seen in the pregnant and postpartum women, but since their oestrogen values are very high it can be assumed that their thioredoxin expression is already at its maximum in relation to the oestradiol stimulation. No correlation was found between thioredoxin mRNA and the serum concentrations of progesterone in any of the groups.
There was an increase in thioredoxin mRNA in the late pregnant and the post-partum cervix, compared with the nonpregnant state. The level of thioredoxin mRNA was not affected after cervical priming with prostaglandin or antiprogestin, when compared with spontaneous ripening. However, there was a tendency for antiprogestin treatment to increase the thioredoxin mRNA value further. Due to the very limited number of biopsies available this finding could not be statistically verified. The increase in the thioredoxin mRNA level both in late pregnant but unripe cervix and in the post-partum cervix, i.e. after the final ripening, indicates that thioredoxin is not of main importance during the fast final ripening which occurs during labour, but possibly in the slow remodelling of the cervix, which occurs before labour, from early pregnancy until term. Thioredoxin has many functions, e.g. co-cytokine activity, co-factor in DNA synthesis and cell proliferation, scavenger of oxygen radicals and as a general disulphide reductase affecting redox regulation of, e.g. transcription factors (Holmgren, 1985; Schenk et al., 1994; Holmgren and Björnstedt, 1995; Blum et al., 1996; Sen and Packer, 1996; Schenk et al., 1996) . All of these functions may take place in the cervix and be of importance for the tissue remodelling. A novel catalytic activity of the mammalian thioredoxin and thioredoxin reductase is cleavage of S-nitrosoglutathione which results in liberation of NO and glutathione and is coupled to oxidation of NADPH (Nikitovic and Holmgren, 1996) . It has been proposed that the NO system may play an active role in the cascade of processes involved in preparing the cervix for parturition (Buhimischi et al., 1996) . Thioredoxin and NO released from nitrothiols could thus be linked by the redox state in the cells, and it is possible that increased levels of thioredoxin in the cervix yield increased levels of NO, which in turn could induce cervical remodelling.
Since the process of cervical ripening has been compared with an inflammatory condition (Liggins, 1981) , and inflammatory cells have been found in cervical tissue (Junqueira et al., 1980) , it implies an important role for thioredoxin in cell protection. The neutrophil, which contains, e.g. collagenase, has been suggested to induce softening and effacement of the cervix at term (Junqueira et al., 1980; Osmers et al., 1992) . Interleukin-8 (IL-8) a chemotactic cytokine for neutrophils, has been shown to induce cervical ripening, by morphological and biochemical criteria, in pregnant guinea pigs (Chwalisz et al., 1994) . IL-8 has also been shown to be under progesterone control in the rabbit cervix (Ito et al., 1994) . Cytokine synthesis is implicated to be tightly controlled by redox-dependent processes and since thioredoxin is readily secreted and taken up by cells it may play an important role as a costimulatory molecule involved in immune processes (Schenk et al., 1996) . Thioredoxin has been found to enhance the mRNA expression for e.g. IL-8 in several celllines (Schenk et al. 1996) . IL-8 is a strong candidate for mediating the final cervical ripening in humans (Barcley et al., 1993; Sennström et al., 1997) and, thus, its activity might be under thioredoxin control.
Thiol redox control via thioredoxin (Holmgren, 1985) is of growing interest for its importance in regulating the binding of transcription factors to DNA (Schenk et al., 1994; Sen and Packer, 1996) . Thus, the AP-1 binding site is present in the promoter region of genes implicated in a number of signal transduction cascades associated with for example growth, transformation and differentiation (Karin, 1991) . The thioredoxin system has been demonstrated to stimulate DNA-binding of the transcription factor AP-1 (Schenk et al., 1994) . The DNA binding of the transcription factor NFκ-B in the nucleus is also facilitated by reduction mediated via the thioredoxin system (Schenk et al., 1994) . Regulation of the activity of transcription factors may thus be an important general mechanism by which the thioredoxin system participates in many different cellular processes.
It has been shown that PGE 2 , as well as antiprogestins, induces cervical softening at term indicating that both prostaglandins and progesterone are of importance for the final ripening process in humans Frydman et al., 1992) . Rajabi et al. (1991a) have shown that 17β-oestradiol stimulated degradation of type I collagen in the non-pregnant cervix from guinea pig in organ culture. Prostaglandins have also been shown to stimulate collagenase activity (Rajabi et al., 1991b) . Thus, it is possible that both oestrogen and progesterone are involved in the process of cervical ripening in humans. The ripening process is associated with an increased collagen turnover resulting in differently organized collagen fibrils. This structural change is necessary for a normal onset and progress of labour (Ekman et al., 1986) . The promoter region of the collagenase gene contains an AP-1 site (Jonat et al., 1992) . Conclusively, oestrogen could be involved in the remodelling of the cervical collagen via stimulation of thioredoxin expression and its subsequent activation of AP-1. As thioredoxin readily pass into cells, it could activate the collagenase gene in cervical stroma cells, which have been shown to be the source of collagenase in guinea pig cervix (Rajabi and Singh, 1995) , as well as in infiltrating leukocytes which have been shown to be the main source of cervical collagenase in humans during parturition (Osmers et al., 1992 ). In addition, one possible role of oestrogens during the cervical remodelling might be to stimulate cell growth via an enhanced thioredoxin production. Thioredoxin is a hydrogen donor of ribonucleotide reductase, which is essential for the reduction of ribonucleotides to deoxyribonucleotides during DNA synthesis (Holmgren and Björnstedt, 1995) , needed for cell proliferation.
Further studies are required to elucidate the function/s of thioredoxin in the human cervix during pregnancy, in particular whether it is involved in collagenase activation and NO liberation. It is also of interest to clarify when the increase in cervical thioredoxin mRNA occurs during pregnancy: immediately after implantation, when the remodelling of the cervix begins or not until late pregnancy. As the expression of the thioredoxin mRNA says nothing about the level of the translated product, we are planning to quantify the thioredoxin protein in the cervix during pregnancy, as well as to establish in-situ hybridization to determine in which cells thioredoxin mRNA is produced.
